Soros Fund Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-15,000	Closed	-$14.4M	–	199
2024 Q1	$14.4M	Sell	15,000 -2,500	-14%	-$2.41M	0.24%	77
2023 Q4	$15.4M	Buy	+17,500	New	+$15.4M	0.2%	76
2016 Q4	–	Sell	-1,381	Closed	-$555K	–	268
2016 Q3	$555K	Buy	+1,381	New	+$555K	0.01%	149